← All candidates
Nine insider buys in the last year — $308.5K in all.
19 filings on record.
TTRXTurn Therapeutics Inc.
NasdaqGM · Healthcare · $273.75M
$9.19
+0.07% · Sep 15
Nine insider buys in the last year — $308.5K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 9 buys◆ 15 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$273.75M
Float
10.8M
36% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Golden Arthur F
Bought $100.0K on Oct 23 — 20,202 sh @ $4.95, held direct, 67% of their stake.
0 of 1 position beat the S&P
Insider
Chesed Abraham
Bought $65.7K on Oct 23 — 14,286 sh @ $4.60, held indirect, 1.0% of their stake.
0 of 1 position beat the S&P
See Remarks
Chaudhary Zuraiz
Bought $25.0K on Oct 23 — 5,050 sh @ $4.95, held direct, 100% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
13 more transactions on Pro →Context
Wall St
$26.00 avg target
+182.9% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 2 quarters beat
Q2 '26−$0.20 act−$0.18
Q1 '26−$0.04 act−$0.02
Coverage
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 ReadoutMarketBeat · 07-11Turn Therapeutics’ stock jumps on AD data and trial expansionClinical Trials Arena · 07-08Turn Therapeutics Completes Interim Phase 2 Review; Expands GX-03 Study in Atopic DermatitisMT Newswires · 07-07Turn Therapeutics Talks GX-03 Phase II Eczema Data Timeline and Non-Systemic Topical StrategyMarketBeat · 03-02
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice